Clinical Trial Update: Study of Apatinib in Metastatic Esophageal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is studying apatinib for metastatic esophageal cancer; the current status of the trial is not disclosed in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Huai'an First People's Hospital | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN